If you have a history of kidney stones or chronic kidney disease, your provider will take that into account when discussing options like Compounded Semaglutide or Compounded Tirzepatide
They are not a blunt instrument
Read more: #ReimagineMedicine #NovartisUS To view or add a comment, sign in The FDA approval of a new oral, targeted therapy for chronic spontaneous urticaria (CSU) changes the treatment landscape for millions of people living with this often-overlooked disease
Some pharmacokinetic studies have examined the lower end of the dose-response curve, but these were conducted to establish appropriate starting doses for titration, not to validate microdosing as a standalone strategy
Risk rises when factors accumulate, for example dose escalation, timing near large meals, existing reflux, or diabetic neuropathy, and a small subset of users, about 1 in 50 (2%), report persistent hiccups that need clinical attention
Why is the IV better than a pill